Trials / Terminated
TerminatedNCT01341730
The Effect of Atorvastatin and Pioglitazone on Carotid Atherosclerosis With the Use of Positron Emission Tomography-computed Tomography (PET-CT)
Evaluation of the Effect of Atorvastatin and Pioglitazone in Carotid Atherosclerosis With the Use of 18Fluoride-Fludeoxyglucose(FDG) Positron Emission Tomography-computed Tomography (PET-CT)Imaging
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 41 (actual)
- Sponsor
- The Catholic University of Korea · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a prospective randomized clinical trial and to compare the antiinflammatory effect of atorvastatin single therapy and atorvastatin and pioglitazone combination therapy in carotid arteries of stable and unstable angina patients by PET/CT.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Atorvastatin 20mg | 20 mg QD for 3 months |
| DRUG | Atorvastatin 20 mg + Pioglitazone 30 mg | atorvastatin 20 mg plus pioglitazone 30 mg QD for 3 months |
Timeline
- Start date
- 2011-06-01
- Primary completion
- 2012-06-01
- Completion
- 2012-08-01
- First posted
- 2011-04-26
- Last updated
- 2020-08-06
- Results posted
- 2020-08-06
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01341730. Inclusion in this directory is not an endorsement.